• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA SELF-EXPANDING STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Catalog Number 42060100-120
Device Problems Patient-Device Incompatibility (2682); Activation Failure (3270)
Patient Problems Embolism/Embolus (4438); Thrombosis/Thrombus (4440)
Event Date 06/16/2022
Event Type  Injury  
Manufacturer Narrative
The customer reported the device is not returning.Investigation is not yet complete.A follow up report will be submitted with all additional relevant information.
 
Event Description
Av-mdr study report.Patient id: (b)(6).It was reported that the procedure was performed to treat a lesion in the heavily calcified 90% stenosed mid right superficial femoral artery (sfa).Pre-dilatation was performed and the 6.0 x 100 mm supera stent was implanted.The stent did not adequately deploy due to heavy calcification and distal thrombus embolization occurred, with thrombus embolizing to the peroneal artery.Additionally, the 100 mm length supera stent was noted to be longer than the target lesion.It was noted that the proximal end of the stent remained in the sheath, so the stent was removed with the delivery system.An absolute pro stent was implanted to treat the target lesion.Thrombectomy and angioplasty were performed to treat the thrombus, resolving the event.No additional information was provided.
 
Event Description
Subsequent to the initial report, additional information was received.The supera stent was unable to fully deploy due to the resistant vessel recoil.The stent was deployed with the proximal end lodged in the sheath.The sheath was cut and the supera stent was grasped with a clamp and removed.The sheath was replaced and an absolute pro stent was successfully implanted.There was no adverse patient sequela.No additional information provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.The reported patient effects of thrombosis and embolism are listed in the supera peripheral stent system instructions for use as known patient effects of coronary procedures.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that due to the resistant vessel recoil the supera stent was unable to fully deploy; thus resulting in the reported patient-device incompatibility recoil and the reported activation failure (proximal end lodged in the sheath).The treatments appears to be related to the operational context of the procedure as reportedly the sheath was cut and the supera stent was grasped with a clamp and removed.The reported difficulties possibly caused/contributed to the reported patient effects however a conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA SELF-EXPANDING STENT SYSTEM
Type of Device
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14982450
MDR Text Key295680081
Report Number2024168-2022-07504
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeSZ
PMA/PMN Number
P120020
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/11/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2022
Device Catalogue Number42060100-120
Device Lot Number0071361
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/12/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/13/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age81 YR
Patient SexFemale
Patient Weight52 KG
-
-